Dr. Dorla Mirejovsky has been appointed senior director of Formulation Development at Irvine Pharmaceutical Services. Dr. Mirejovsky has more than 25 years of experience in pharmaceutical development, drug delivery, and manufacturing of injectable drugs.

Dr. Mirejovsky most recently was responsible for the development and manufacture of several drug candidates at Spectrum Pharmaceuticals, where she authored CMC submissions for one NDA and several INDs. Previously, she spent nine years at Sicor Pharmaceuticals developing numerous injectable products including Propofol Injectable Emulsion. Dr. Mirejovsky has had similar roles at ISIS Pharmaceuticals and Allergan.